Barclays PLC Innoviva, Inc. Put Options Transaction History

Barclays PLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $8,376 - $10,956	-600 Reduced 66.67%	300 $5,000
Q3 2018 Nov 14, 2018	SELL	$13.63 - $15.7 $2,726 - $3,140	-200 Reduced 18.18%	900 $14,000
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $5,376 - $7,036	400 Added 57.14%	1,100 $15,000
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $8,280 - $10,193	600 Added 600.0%	700 $12,000
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $1,206 - $1,412	100	100 $1,000

225

78.8M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.3B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.